Notice of a collaboration agreement with Renascience, Inc. to develop antisense oligonucleotides for treating hereditary neurological intractable diseases 2024/06/24 Notice Read
Notice:Luxna Biotech and Head Office for Open Innovation Business Development Strategy, Tohoku University Announce the Initiation of the Collaborative Research for Creation of Antisense Oligonucleotide for the Treatment of Hearing Loss 2023/12/22 Notice Read
We are selected as finalists for “Citeline Pharma Intelligence Awards Japan 2023”. 2023/09/26 Notice Read
The collaborative research of Luxna Biotech with Sekisui Medical CO., Ltd. on a higly-sensitve detection methods of antisense oligonucleotides has been published in the journal, the BioTechniques. 2023/07/03 Notice Read